Annovis Bio Inc and Neurodegenerative Diseases
Annovis Bio Inc (ANVS), a clinical-stage drug platform company. This firm's focus is the treatment of neurodegenerative diseases.
Annovis Bio Inc announced today new results from a double-blind, placebo-controlled study of its product ANVS401, the Company's lead . . .
This content is for paid subscribers.
Today’s Highlights
May 21, 2021
